wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38911819-BAAB9411-30C2-4445-888A-F72862FF002B
Q38911819-BAAB9411-30C2-4445-888A-F72862FF002B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38911819-BAAB9411-30C2-4445-888A-F72862FF002B
Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada.
P2860
Q38911819-BAAB9411-30C2-4445-888A-F72862FF002B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38911819-BAAB9411-30C2-4445-888A-F72862FF002B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d13a11cbad1dbc105180e11261e8f3a9fb898f37
P2860
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada